Prudential Financial
INSY

Prudential Financial’s Insys Therapeutics, Inc. INSY Stock Holding History

Prudential Financial’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-10,370
Closed -$166K – 2356
2016
Q1 		$166K Buy
10,370
+600
+6% +$11.4K ﹤0.01% 2213
2015
Q4 		$280K Buy
+9,770
New +$271K ﹤0.01% 2084
2015
Q3 		– Sell
-33,090
Closed -$1.19M – 2279
2015
Q2 		$1.19M Buy
+33,090
New +$1.03M ﹤0.01% 1760

Other funds holding INSY

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FHAM
Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $310M AUM 37.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Prudential Financial's INSY Position: Q2 2016 in Review

Prudential Financial sold out of Insys Therapeutics, Inc. (INSY) in Q2 2016, closing a stake of 10,370 shares — an estimated $166K sold.

Prudential Financial first reported a position in INSY in Q2 2015 and held it in 3 quarters. The position peaked at $1.19M in Q2 2015. 124 funds tracked by Wall St. Rank hold INSY as of Q2 2016.

  • Prudential Financial reported no remaining Insys Therapeutics, Inc. position as of Q2 2016 after selling out during the quarter.
  • Prudential Financial sold 10,370 Insys Therapeutics, Inc. shares in Q2 2016, an estimated $166K.
  • Prudential Financial first reported a position in Insys Therapeutics, Inc. in Q2 2015 and held it in 3 quarters.
  • Prudential Financial's Insys Therapeutics, Inc. position peaked at $1.19M in Q2 2015.
  • 124 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2016.

Based on Prudential Financial's 13F filing for Q2 2016, filed 9 Aug 2016.